The global custom gene expression market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising prevalence of chronic diseases. The market is also driven by the need for customized gene expression analysis in research and development activities in pharmaceuticals, biotechnology, and medical devices industries. The below 1000 bp segment accounted for the largest share of the global custom gene expression market in 2018 owing to its high accuracy level and low cost per sample. However, this segment is expected to witness a decline during the forecast period due to its limited application scope. The 1001 3000 bp segment accounted for a significant share of the global custom gene expression market in 2018 owing to its wide application scope across various fields such as academic research, commercial applications, clinical diagnostics, drug discovery & development etc, which are driving factors for this segment's growth during the forecast period.
Some Of The Growth Factors Of This Market:
- The market for Custom Gene Expression is expected to reach $3,890 million by 2025.
- Increasing prevalence of chronic diseases such as cancer and diabetes are driving the growth of the Custom Gene Expression market.
- Increasing demand for personalized medicine and increasing number of research & development activities in this field are also driving the growth of the Custom Gene Expression market.
- Lack of skilled professionals in this field is a major restraint on the growth of this market.
Industry Growth Insights published a new data on “Custom Gene Expression Market”. The research report is titled “Custom Gene Expression Market research by Types (Below 1000 bp, 1001 - 3000 bp, 3001- 5000 bp, Above 5000 bp), By Applications (Academic Research, Commercial), By Players/Companies Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Custom Gene Expression Market Research Report
By Type
Below 1000 bp, 1001 - 3000 bp, 3001- 5000 bp, Above 5000 bp
By Application
Academic Research, Commercial
By Companies
Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Custom Gene Expression Market Report Segments:
The global Custom Gene Expression market is segmented on the basis of:
Types
Below 1000 bp, 1001 - 3000 bp, 3001- 5000 bp, Above 5000 bp
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research, Commercial
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genescript
- GeneArt (Thermofischer)
- IDT
- DNA 2.0 (ATUM)
- OriGene
- BBI
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Bio Basic
Highlights of The Custom Gene Expression Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Below 1000 bp
- 1001 - 3000 bp
- 3001- 5000 bp
- Above 5000 bp
- By Application:
- Academic Research
- Commercial
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Custom Gene Expression Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Custom gene expression is a process by which cells in the body can be directed to produce specific proteins or other molecules. This process can be used to treat diseases or improve the function of cells.
Some of the key players operating in the custom gene expression market are Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic.
The custom gene expression market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Custom Gene Expression Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Custom Gene Expression Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Custom Gene Expression Market - Supply Chain
4.5. Global Custom Gene Expression Market Forecast
4.5.1. Custom Gene Expression Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Custom Gene Expression Market Size (000 Units) and Y-o-Y Growth
4.5.3. Custom Gene Expression Market Absolute $ Opportunity
5. Global Custom Gene Expression Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Custom Gene Expression Market Size and Volume Forecast by Type
5.3.1. Below 1000 bp
5.3.2. 1001 - 3000 bp
5.3.3. 3001- 5000 bp
5.3.4. Above 5000 bp
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Custom Gene Expression Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Custom Gene Expression Market Size and Volume Forecast by Application
6.3.1. Academic Research
6.3.2. Commercial
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Custom Gene Expression Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Custom Gene Expression Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Custom Gene Expression Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Custom Gene Expression Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Custom Gene Expression Demand Share Forecast, 2019-2029
9. North America Custom Gene Expression Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Custom Gene Expression Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Custom Gene Expression Market Size and Volume Forecast by Application
9.4.1. Academic Research
9.4.2. Commercial
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Custom Gene Expression Market Size and Volume Forecast by Type
9.7.1. Below 1000 bp
9.7.2. 1001 - 3000 bp
9.7.3. 3001- 5000 bp
9.7.4. Above 5000 bp
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Custom Gene Expression Demand Share Forecast, 2019-2029
10. Latin America Custom Gene Expression Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Custom Gene Expression Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Custom Gene Expression Market Size and Volume Forecast by Application
10.4.1. Academic Research
10.4.2. Commercial
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Custom Gene Expression Market Size and Volume Forecast by Type
10.7.1. Below 1000 bp
10.7.2. 1001 - 3000 bp
10.7.3. 3001- 5000 bp
10.7.4. Above 5000 bp
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Custom Gene Expression Demand Share Forecast, 2019-2029
11. Europe Custom Gene Expression Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Custom Gene Expression Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Custom Gene Expression Market Size and Volume Forecast by Application
11.4.1. Academic Research
11.4.2. Commercial
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Custom Gene Expression Market Size and Volume Forecast by Type
11.7.1. Below 1000 bp
11.7.2. 1001 - 3000 bp
11.7.3. 3001- 5000 bp
11.7.4. Above 5000 bp
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Custom Gene Expression Demand Share, 2019-2029
12. Asia Pacific Custom Gene Expression Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Custom Gene Expression Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Custom Gene Expression Market Size and Volume Forecast by Application
12.4.1. Academic Research
12.4.2. Commercial
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Custom Gene Expression Market Size and Volume Forecast by Type
12.7.1. Below 1000 bp
12.7.2. 1001 - 3000 bp
12.7.3. 3001- 5000 bp
12.7.4. Above 5000 bp
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Custom Gene Expression Demand Share, 2019-2029
13. Middle East & Africa Custom Gene Expression Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Custom Gene Expression Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Custom Gene Expression Market Size and Volume Forecast by Application
13.4.1. Academic Research
13.4.2. Commercial
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Custom Gene Expression Market Size and Volume Forecast by Type
13.7.1. Below 1000 bp
13.7.2. 1001 - 3000 bp
13.7.3. 3001- 5000 bp
13.7.4. Above 5000 bp
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Custom Gene Expression Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Custom Gene Expression Market: Market Share Analysis
14.2. Custom Gene Expression Distributors and Customers
14.3. Custom Gene Expression Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Genescript
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GeneArt (Thermofischer)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. IDT
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DNA 2.0 (ATUM)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. OriGene
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BBI
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Genewiz
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eurofins Genomics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Gene Oracle
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SBS Genetech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bio Basic
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook